ArticleNanomaterials (Basel, Switzerland)2020
Synthesis of Biogenic Silver Nanoparticles (AgCl-NPs) Using a
Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 89 citations in OpenAlex.
- Bioengineered Ag/AgCl nanoparticles fromNanoscale advances · 2026Article
- Green silver nanoparticles of Khaya senegalensis as dual inhibitors of viral thymidine kinase and 3 C protease: metabolomics, and computational insights.Scientific reports · 2026Article
- Phytosynthesis of Ag@AgCl nanoparticles using two types of bionanotechnological protocols exhibiting unique antimicrobial, antioxidant, and anti-inflammatory properties.Frontiers in bioengineering and biotechnology · 2026Article
- Green Synthesis of Ag/AgCl Nanoparticles From Argan Oil Waste: Characterization, Antibacterial, and Cytotoxicity Activities.Food science & nutrition · 2025Article
- Green synthesis of silver nanoparticles from plant Astragalus fasciculifolius Bioss and evaluating cytotoxic effects on MCF7 human breast cancer cells.Scientific reports · 2025Article
- Removal of Zn(II) and Ag(I) byToxics · 2025Article
- Green Synthesis of Biogenic Nano Zerovalent Iron UsingACS omega · 2025Article
- Article
- Silver nanoparticles synthesized using aerial part of Achillea fragrantissima and evaluation of their bioactivities.Scientific reports · 2024Article
- Article
- Rosmarinic Acid-RichMolecules (Basel, Switzerland) · 2024Article
- Formation Kinetics and Antimicrobial Activity of Silver Nanoparticle Dispersions Based on N-Reacetylated Oligochitosan Solutions for Biomedical Applications.Pharmaceutics · 2023Article
- Biological properties of experimental dental alginate modified for self-disinfection using green nanotechnology.Clinical oral investigations · 2023Article
- Innovative Eco-Friendly Microwave-Assisted Rapid Biosynthesis of Ag/AgCl-NPs Coated with Algae Bloom Extract as Multi-Functional Biomaterials with Non-Toxic Effects on Normal Human Cells.Nanomaterials (Basel, Switzerland) · 2023Article
- Green synthesis of copper oxide nanoparticles usingHeliyon · 2023Article
- Green Synthesis of Flower-Like Carrageenan-Silver Nanoparticles and Elucidation of Its Physicochemical and Antibacterial Properties.Molecules (Basel, Switzerland) · 2023Article
- Exploring Physical Characterization and Different Bio-Applications ofMolecules (Basel, Switzerland) · 2023Article
- Article
- Biogenic silver nanoparticles as antifungal agents.Frontiers in chemistry · 2022Review
- Pharmacological activities and gas chromatography-mass spectrometry analysis for the identification of bioactive compounds fromFrontiers in pharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, very simple and fast one-step synthesis of biogenic silver chloride nanoparticles (AgCl-NPs) using a
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.